文献速递功能神经外科

影像引导机器人放射外科治疗三叉神经痛

Image-Guided Robotic Radiosurgery for Trigeminal Neuralgia.
PubMed 文献 · Neurosurgery · 2018-01-01

单中心回顾性分析138例药物难治性三叉神经痛患者接受CyberKnife®无框架非等中心放射外科治疗,中位随访52.4个月。中位处方剂量60 Gy(80%等剂量线),6、12、24、36个月疼痛控制率分别为93.5%、85.8%、79.7%、76%。靶向6 mm段三叉神经、处方剂量60 Gy似乎安全有效,感觉并发症多发生于再照射后。

要点

  • 靶向6 mm段三叉神经、处方剂量60 Gy似乎安全有效。
  • 6、12、24、36个月疼痛控制率分别为93.5%、85.8%、79.7%、76%。
  • 再照射独立预测感觉障碍(P < .001)。

核心结论

  • 靶向6 mm段三叉神经、处方剂量60 Gy似乎安全有效,多数患者获得持续疼痛控制,感觉并发症风险可接受,且通常见于再照射后。

研究设计与样本

  • 单中心经验,纳入138例接受CyberKnife®放射外科治疗且随访至少36个月的三叉神经痛患者,前瞻性分析疼痛缓解、药物、感觉障碍及疼痛复发率和时间。

主要发现

  • 中位随访52.4个月,中位剂量75 Gy,中位靶区长度5.7 mm,中位靶区体积40 mm³,中位处方剂量60 Gy(80%等剂量线)。
  • 6、12、24、36个月疼痛控制率(BNI I-IIIa级)分别为93.5%、85.8%、79.7%、76%。
  • 33例(24%)需要第二次治疗;18.1%在16.4 ± 8.7个月后出现感觉障碍。
  • 1例(0.7%)出现BNI IV级功能障碍;6例(4.3%)在再治疗后出现BNI III级(有些困扰)感觉减退;18例报告BNI II级(不困扰)感觉减退(其中11例在再治疗后)。
  • 神经长度较短(<6 mm vs 6 mm)、神经体积较小(<30 mm³ vs >30 mm³)和处方剂量较低(<58 vs >58 Gy)与治疗失败相关(P = .01,P = .02,P = .03)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Frameless, non-isocentric irradiation of an extended segment of the trigeminal nerve introduces new concepts in stereotactic radiosurgery for medically resistant trigeminal neuralgia (TN). OBJECTIVE: To report the results of the largest single-center experience about image-guided robotic radiosurgery for TN. METHODS: A cohort of 138 patients treated with CyberKnife® (Accuray Incorporated, Sunnyvale, California) radiosurgery with a minimum follow-up of 36 mo were recruited. Pain relief, medications, sensory disturbances, rate and time of pain recurrence were prospectively analyzed. RESULTS: Median follow-up was 52.4 mo; median dose 75 Gy; median target length 5.7-mm; median target volume 40 mm³; median prescription dose 60 Gy (80% isodose line). Actuarial pain control rate (Barrow Neurological Institute [BNI] class I-IIIa) at 6, 12, 24, and 36 mo were 93.5%, 85.8%, 79.7%, and 76%, respectively. Overall, 33 patients (24%) required a second treatment. Overall, 18.1% developed sensory disturbances after 16.4 ± 8.7 mo. One patient (0.7%) developed BNI grade IV dysfunction; 6 (4.3%) developed BNI grade III (somewhat bothersome) hypoesthesia after retreatment; BNI grade II (not bothersome) hypoesthesia was reported by 18 patients (11 after retreatment). Shorter nerve length (<6 mm vs 6 mm), smaller nerve volume (<30 mm3 vs >30 mm3), and lower prescription dose (<58 vs >58 Gy) were associated with treatment failure (P = .01, P = .02, P = .03, respectively). Re-irradiation independently predicted sensory disturbance (P < .001). CONCLUSION: Targeting a 6-mm segment of the trigeminal nerve with a prescribed dose of 60 Gy appears safe and effective. Persistent pain control was achieved in most patients with acceptable risk of sensory complications, which were typically found after re-irradiation.

来源:Neurosurgery,查看原文。版权归原作者所有。

引用

  1. Romanelli P, Conti A, Bianchi L, et al. Image-Guided Robotic Radiosurgery for Trigeminal Neuralgia. Neurosurgery. 2018. PMID: 29294132. doi:10.1093/neuros/nyx571

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。